BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 16970637)

  • 21. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of Cardiometabolic Health as Midlife Women Transition to Menopause: A Prospective Multiethnic Study.
    Ward E; Gold EB; Johnson WO; Ding F; Chang PY; Song P; El Khoudary SR; Karvonen-Gutierrez C; Ylitalo KR; Lee JS
    J Clin Endocrinol Metab; 2019 May; 104(5):1404-1412. PubMed ID: 30365014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
    Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
    J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of new criterion of glucose level on the prevalence of impaired fasting glucose and risk of ischemic cardiovascular diseases].
    Wang W; Zhao D; Sun JY; Liu J; Qin LP; Wu ZS
    Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):20-4. PubMed ID: 17331382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.
    Beltrán-Sánchez H; Harhay MO; Harhay MM; McElligott S
    J Am Coll Cardiol; 2013 Aug; 62(8):697-703. PubMed ID: 23810877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study.
    Hadaegh F; Abdi A; Kohansal K; Hadaegh P; Azizi F; Tohidi M
    Front Endocrinol (Lausanne); 2023; 14():1164771. PubMed ID: 37305040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population.
    He Y; Jiang B; Wang J; Feng K; Chang Q; Fan L; Li X; Hu FB
    J Am Coll Cardiol; 2006 Apr; 47(8):1588-94. PubMed ID: 16630995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study.
    Misra R; Patel T; Kotha P; Raji A; Ganda O; Banerji M; Shah V; Vijay K; Mudaliar S; Iyer D; Balasubramanyam A
    J Diabetes Complications; 2010; 24(3):145-53. PubMed ID: 19303333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors.
    Walker SE; Gurka MJ; Oliver MN; Johns DW; DeBoer MD
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):141-8. PubMed ID: 20708390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, associated factors and heritabilities of metabolic syndrome and its individual components in African Americans: the Jackson Heart Study.
    Khan RJ; Gebreab SY; Sims M; Riestra P; Xu R; Davis SK
    BMJ Open; 2015 Nov; 5(10):e008675. PubMed ID: 26525420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
    Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051
    [No Abstract]   [Full Text] [Related]  

  • 37. Impaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndrome.
    Onat A; Aydın M; Can G; Cakmak HA; Köroğlu B; Kaya A; Ademoğlu E
    World J Diabetes; 2013 Oct; 4(5):210-8. PubMed ID: 24147205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial.
    Gomez-Sanchez L; Garcia-Ortiz L; Patino-Alonso MC; Recio-Rodriguez JI; Fernando R; Marti R; Agudo-Conde C; Rodriguez-Sanchez E; Maderuelo-Fernandez JA; Ramos R; Gomez-Marcos MA;
    Cardiovasc Diabetol; 2016 Oct; 15(1):148. PubMed ID: 27776526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Yonemoto K; Arima H; Kubo M; Tanizaki Y; Iwase M; Iida M; Kiyohara Y
    Stroke; 2009 Apr; 40(4):1187-94. PubMed ID: 19265058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial/ethnic differences in the association of triglycerides with other metabolic syndrome components: the Multi-Ethnic Study of Atherosclerosis.
    Lin SX; Carnethon M; Szklo M; Bertoni A
    Metab Syndr Relat Disord; 2011 Feb; 9(1):35-40. PubMed ID: 20958206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.